Loading...

Financial Summary


Abbott Laboratories

Abbott Laboratories (ABT)

Healthcare
Buy
A+
Market Info
Financial Info
Financial Modelling
Symbol ABT
Price 85.82$
Beta 1.12
Volume Avrg. 6.52M
Market Cap 151.89B
Shares (2018) 1,770,000.00K
Last Div 1.28
Dividend Yield Infinity%
DCF Unlevered 58.72 Strong Sell
DCF Levered 38.16 Strong Sell
ROE 7.71% Neutral
ROA 17.96% Buy
Operating Margin 11.94% Buy
Debt / Equity 63.69% Buy
P/E 53.98 Strong Buy
P/B 4.15 Strong Buy

Income Statement

Download ABT income statement Download ABT income statement
Year 2009201020112012201320142015201620172018
Revenue 30,764.7135,166.7221,407.0019,050.0019,657.0020,247.0020,405.0020,853.0027,390.0030,578.00
Cost of Revenue 13,209.3314,665.1910,017.008,899.009,193.009,218.008,747.009,094.0012,409.0012,706.00
Gross Profit 17,555.3820,501.5311,390.0010,151.0010,464.0011,029.0011,658.0011,759.0014,981.0017,872.00
R&D Expenses 2,743.733,724.421,512.001,461.001,371.001,345.001,405.001,447.002,260.002,300.00
Sales, General and Administrative Expense 8,405.9010,376.327,365.006,735.006,372.006,530.006,785.006,736.009,182.009,744.00
Operating Expenses 11,319.6414,413.959,761.008,791.008,331.008,430.008,791.008,733.0013,417.0014,222.00
Operating Income 6,235.746,087.581,629.001,360.002,133.002,599.002,867.003,026.001,564.003,650.00
Interest Expense 519.66553.13359.00320.00145.00150.00163.00431.00904.00826.00
Earnings before Tax 7,193.775,712.834,838.005,506.002,629.003,081.005,000.001,750.002,355.002,907.00
Income Tax Expense 1,447.941,086.66110.00-457.0053.00797.00577.00350.001,878.00539.00
Net Income 5,745.844,626.174,728.005,963.002,576.002,284.004,423.001,400.00477.002,368.00
Net Income - Non-Controlling int ----------
Net Income - Discounted ops ----------
Net Income Com 5,745.844,626.174,728.005,963.002,576.002,284.004,423.001,400.00477.002,368.00
Preferred Dividends ----------
Earnings Per Share Basic 3.712.983.033.761.641.502.940.940.271.34
Earnings Per Share Diluted 3.692.963.013.721.621.492.920.940.271.33
Weighted Average Shares Outstanding 1,546.981,546.401,557.001,575.001,558.001,516.001,496.001,477.001,740.001,758.00
Weighted Average Shares Outstanding (Diluted) 1,555.131,556.021,567.001,592.001,574.001,527.001,506.001,483.001,749.001,770.00
Dividend per Share 0.000.000.000.000.000.000.000.000.000.00
Gross Margin 0.570.580.530.530.530.540.570.560.550.58
EBITDA Margin 0.320.250.390.450.230.240.330.170.230.23
EBIT Margin 0.250.180.240.310.140.160.250.100.120.12
Profit Margin 0.190.130.220.310.130.110.220.070.020.08
Free Cash Flow margin 0.000.000.000.000.000.000.000.000.000.00
EBITDA 9,802.948,890.278,241.008,608.004,493.004,779.006,635.003,534.006,280.007,011.00
EBIT 7,713.436,265.975,197.005,826.002,774.003,231.005,163.002,181.003,259.003,733.00
Consolidated Income 5,745.844,626.174,728.005,963.002,576.002,284.004,423.001,400.00477.002,368.00
Earnings Before Tax Margin 0.230.160.230.290.130.150.240.080.090.10
Net Profit Margin 0.190.130.220.310.130.110.220.070.020.08

Balance Sheet Statement

Download ABT income statement Download ABT income statement
Year 2009201020112012201320142015201620172018
Cash and cash equivalents 9,932.055,451.458,097.3615,174.008,098.004,460.006,125.0018,775.009,610.003,844.00
Short-term investments -1,872.49-------242.00
Cash and short-term investments 9,932.057,323.948,097.3615,174.008,098.004,460.006,125.0018,775.009,610.004,086.00
Receivables 6,541.947,184.037,683.927,613.003,986.003,586.003,418.003,248.005,249.005,182.00
Inventories 3,264.883,188.733,284.253,793.002,693.002,643.002,599.002,434.003,601.003,796.00
Property, Plant & Equipment Net 7,619.497,970.967,873.958,063.005,905.005,935.005,730.005,705.007,607.007,563.00
Goodwill and Intangible Assets 19,492.1628,081.7125,695.0224,362.0015,507.0016,265.0015,200.0012,222.0045,493.0042,196.00
Long-term investments 1,132.87302.05378.23274.00119.00229.004,041.002,947.00883.00897.00
Tax assets 3,387.364,977.665,261.466,199.004,637.003,288.002,119.002,263.001,944.001,885.00
Total non-current assets 16,344.7420,546.2920,270.5227,142.008,179.009,101.0010,735.0025,289.0036,240.0027,439.00
Total current assets 29,267.7338,256.3236,508.1235,912.0023,706.0027,651.0027,092.0025,890.0056,103.0052,541.00
Total assets 52,581.6260,573.8560,276.8967,235.0042,953.0041,207.0041,247.0052,666.0076,250.0067,173.00
Payables 1,280.541,535.761,721.131,797.001,026.001,064.001,081.001,178.002,402.002,975.00
Short-term debt 5,189.626,394.773,374.762,391.003,173.004,437.003,130.001,325.00714.00207.00
Total current liabilities 13,049.4917,262.4315,480.2313,280.009,507.0010,467.009,186.006,660.008,912.009,012.00
Long-term debt 11,266.2912,523.5212,039.8218,085.003,388.003,393.005,871.0020,681.0027,210.0019,359.00
Total debt 16,455.9118,918.2815,414.5820,476.006,561.007,830.009,001.0022,006.0027,924.0019,566.00
Deferred revenue ----------
Tax Liabilities 442.141,307.72514.95655.00175.00270.00430.00188.00309.00305.00
Deposit Liabilities ----------
Total non-current liabilities 16,344.7420,546.2920,270.5227,142.008,179.009,101.0010,735.0025,289.0036,240.0027,439.00
Total liabilities 29,394.2337,808.7235,750.7540,422.0017,686.0019,568.0019,921.0031,949.0045,152.0036,451.00
Other comprehensive income 854.07-1,366.85-2,597.18-3,594.00-2,012.00-5,053.00-6,658.00-7,263.00-6,062.00-7,586.00
Retained earnings (deficit) 17,342.6919,215.7720,907.3624,151.0021,979.0022,874.0025,757.0025,565.0023,978.0024,560.00
Total stockholders equity ----------
Investments 1,132.872,174.54378.23274.00119.00229.004,041.002,947.00883.001,139.00
Net Debt 6,523.8711,594.347,317.225,302.00-1,537.003,370.002,876.003,231.0018,314.0015,480.00
Other Assets 3,575.034,620.824,703.254,743.004,470.002,867.002,013.002,319.001,687.001,568.00
Other Liabilities 6,579.339,331.9110,384.359,092.005,308.004,966.004,975.004,157.005,796.005,830.00

Cash Flow Statement

Download ABT income statement Download ABT income statement
Year 2009201020112012201320142015201620172018
Depreciation & Amortization 2,089.512,624.303,044.002,782.001,719.001,548.001,472.001,353.003,021.003,278.00
Stock-based compensation 366.36387.18383.00433.00262.00246.00292.00310.00406.00477.00
Operating Cash Flow 7,275.168,735.988,970.009,314.003,324.003,675.002,966.003,203.005,570.006,300.00
Capital Expenditure -1,089.05-1,015.08-1,491.00-1,795.00-1,145.00-1,077.00-1,110.00-1,121.00-1,135.00-1,394.00
Acquisitions and disposals -2,370.63-9,433.24-273.00-706.00-580.00-3,312.002,285.00-55.00-8,437.0048.00
Investment purchases and sales -232.66148.43539.00-3,062.00-2,225.004,117.00-821.00886.00-81.00-58.00
Investing Cash Flow ----------
Insurance (repayment) of debt ----------
Insurance (buybacks) of shares ----------
Dividend payments -2,414.46-2,671.47-2,938.00-3,183.00-882.00-1,342.00-1,443.00-1,539.00-1,849.00-1,974.00
Financing Cash Flow 1,002.02-1,087.74-6,423.00195.00-6,696.00-2,742.00-2,236.0011,147.00-5,281.00-10,391.00
Effect of forex changes on cash 118.85-620.89-43.0040.00-26.00-143.00-198.00-483.00116.00-116.00
Net cash flow / Change in cash 4,697.32-5,160.973,165.003,989.00-7,327.00588.00938.0013,619.00-9,213.00-5,563.00
Free Cash Flow 6,186.117,720.917,479.007,519.002,179.002,598.001,856.002,082.004,435.004,906.00
Net Cash/Marketcap -0.00-0.00-0.00-0.000.00-0.00-0.00-0.00-0.00-0.00

Retained Earning Schedule

Year 2009201020112012201320142015201620172018
Retained Earnings (Previous Year) -17,34319,21620,90724,15121,97922,87425,75725,56523,978
Net Income 5,7464,6264,7285,9632,5762,2844,4231,4004772,368
Stock Dividends 14,011-82-98464-3,866-47-97-53-215188
Divident Paid -2,414-2,671-2,938-3,183-882-1,342-1,443-1,539-1,849-1,974
Retained Earnings 17,34319,21620,90724,15121,97922,87425,75725,56523,97824,560
Year 2009201020112012201320142015201620172018
Gross PPE -7,6197,9717,8748,0635,9055,9355,7305,7057,607
Annual Depreciation 8,7091,3671,3941,984-1,0131,1079051,0963,0371,350
Capital Expenditure -1,089-1,015-1,491-1,795-1,145-1,077-1,110-1,121-1,135-1,394
Net PPE 7,6197,9717,8748,0635,9055,9355,7305,7057,6077,563

Intangible and Goodwill Schedule

Year 2009201020112012201320142015201620172018
Intangible and Goodwill (Previous Year) -19,49228,08225,69524,36215,50716,26515,20012,22245,493
New Purchases -233148539-3,062-2,2254,117-821886-81-58
Intangible and Goodwill 19,49228,08225,69524,36215,50716,26515,20012,22245,49342,196
Abbott Laboratories

Abbott Laboratories (ABT)

85.82
-0.12 (-0.13%)

About


Miles D. White
Healthcare
Drug Manufacturers
New York Stock Exchange

Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.